AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2020
Aug 20, 2020
30016_dirs_2020-08-20_116e1a6b-5aa1-4562-ab83-3b8e7c3060a5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2020-08-18
Reporting Person: MCKEON BRIAN P (Executive VP & CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-08-18 | Common Stock | M | 1880 | $53.185 | Acquired | 51486 | Direct |
| 2020-08-18 | Common Stock | M | 1256 | $79.54 | Acquired | 52732 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-08-18 | Incentive Stock Option (right-to-buy) | $53.185 | M | 1880 | Disposed | 2023-12-31 | Common Stock (1880) | Direct |
| 2020-08-18 | Incentive Stock Option (right-to-buy) | $79.54 | M | 1256 | Disposed | 2025-02-13 | Common Stock (1256) | Direct |
Footnotes
F1: Grant of option to buy 4,700 shares of Issuer common stock that vested in five annual installments beginning on January 1, 2015. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015 (the "Stock Split").
F2: Grant of option to buy 628 shares of Issuer common stock that vested on February 14, 2020. The number of derivative securities reported as beneficially owned and price with respect to this option were adjusted to reflect the Stock Split.
F3: Not applicable.